Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/E3CBC112.svg?ark=w1%2F20260526%2FE3CBC112)](https://nobleid.org/work/w1/20260526/E3CBC112)

ARK Inflections

Authors & Claims

Paper Authors